Full Text
How influential are Patient and professional group submissions on reimbursement decisions for European Medicines Agency Orphan Drugs?

Abstract

Authors

R. Chang L. Versoza A. Jaksa Y. Ho

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×